BARCLAYS PLC - TEVA PHARMACEUTICAL FIN LLC ownership

TEVA PHARMACEUTICAL FIN LLC's ticker is and the CUSIP is 88163VAE9. A total of 51 filers reported holding TEVA PHARMACEUTICAL FIN LLC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.5%.

Quarter-by-quarter ownership
BARCLAYS PLC ownership history of TEVA PHARMACEUTICAL FIN LLC
ValueSharesWeighting
Q4 2019$133,000
+478.3%
140,000
+460.0%
0.00%
Q3 2019$23,000
-87.8%
25,000
-88.0%
0.00%
Q4 2018$188,000
+652.0%
208,000
+670.4%
0.00%
Q3 2018$25,000
-94.5%
27,000
-94.5%
0.00%
Q2 2018$451,000
+1309.4%
487,000
+1216.2%
0.00%
Q1 2018$32,000
-68.0%
37,000
-66.7%
0.00%
Q3 2017$100,000
-2.9%
111,000
+18.1%
0.00%
Q4 2016$103,000
-75.3%
94,000
-69.6%
0.00%
-100.0%
Q3 2015$417,000
+1.0%
309,000
+4.0%
0.00%
Q2 2015$413,000
+4.0%
297,000
+10.8%
0.00%
Q1 2015$397,000
+58.8%
268,000
+45.7%
0.00%
Q4 2014$250,000
+2.0%
184,000
-4.2%
0.00%
Q3 2014$245,000
+26.9%
192,000
+26.3%
0.00%
Q2 2014$193,000
+36.9%
152,000
+35.7%
0.00%
Q1 2014$141,000
-25.8%
112,000
-37.4%
0.00%
Q4 2013$190,000
-26.4%
179,000
-28.7%
0.00%
Q3 2013$258,000
+62.3%
251,000
+65.1%
0.00%
Q2 2013$159,000152,0000.00%
Other shareholders
TEVA PHARMACEUTICAL FIN LLC shareholders Q1 2019
NameSharesValueWeighting ↓
ZAZOVE ASSOCIATES LLC 83,413,000$130,650,0006.13%
AEGON USA Investment Management, LLC 6,000,000$9,368,0002.35%
MACKAY SHIELDS LLC 24,370,000$38,152,0002.07%
INCOME RESEARCH & MANAGEMENT 4,374,000$6,829,0001.11%
KINGDON CAPITAL MANAGEMENT, L.L.C. 20,000$20,347,0000.99%
SHENKMAN CAPITAL MANAGEMENT INC 5,269,000$8,264,0000.82%
Mitsubishi UFJ Securities Holdings Co., Ltd. 325,000$511,0000.76%
PALISADE CAPITAL MANAGEMENT, LP 9,299,000$14,598,0000.47%
ADVENT CAPITAL MANAGEMENT /DE/ 14,543,000$23,021,0000.35%
CSS LLC/IL 3,750,000$5,893,0000.35%
View complete list of TEVA PHARMACEUTICAL FIN LLC shareholders